Académique Documents
Professionnel Documents
Culture Documents
Jesus
Maldonado
B.S.
Biochemistry/Biomedical
Engineering
The
University
of
Texas
at
Austin
Jesus
Maldonado
B.S.
Biochemistry/Biomedical
Engineering
The
University
of
Texas
at
Austin
List
of
Hallmarks:
The
following
figure
serves
as
the
basis
for
the
discussion
below
about
the
mechanisms
that
cancer
undergoes.
A
cancer
cell
may
at
any
point
acquire
one
of
the
following
hallmarks
of
cancer,
even
without
an
enabling
characteristic
(as
shown
above).
The
point
at
which
cancerous
cells
acquire
these
capabilities
is
not
dependent
on
any
other
point:
they
can
acquire
these
capabilities,
either
multiple
ones
or
all,
and
cancer
can
result
as
a
result
of
these
mutations.
1. Deregulation
of
Cellular
Metabolism
a. Cancer
cells
show
an
increased
usage
of
an
inefficient
energy-‐
harvesting
process:
the
conversion
of
glucose,
one
of
the
basic
sugars,
to
pyruvate,
a
compound
used
to
yield
high
amounts
of
energy
in
a
process
called
chemiosmotic
phosphorylation.
Normally,
the
conversion
of
glucose
to
pyruvate
is
just
a
first
step
in
the
process
of
energy
harvesting
in
a
cell.
In
order
to
supply
the
increased
energetic
demands
of
the
cell,
cancer
cells
increase
the
amount
of
glucose
Jesus
Maldonado
B.S.
Biochemistry/Biomedical
Engineering
The
University
of
Texas
at
Austin
transported
inside
by
increasing
the
synthesis
of
glucose
transporters.
Despite
the
low
energy
efficiency,
scientists
hypothesize
that
the
increase
in
glucose
metabolism
occurs
because
the
process
yields
several
intermediates.
These
go-‐betweens
are
important
building
blocks
for
other
compounds
necessary
for
the
cancerous
cell,
amino
acids.
2. Invasion
and
Metastasis
a. Tumor
cells
can
acquire
the
ability
to
invade
other
nearby
tissues
and
even
other
parts
of
the
body
through
the
lymphatic
and
circulatory
system.
Invasive
cancer
cells
lose
the
proteins
that
anchor
them
to
other
cells,
such
as
E-‐cadherin,
enabling
the
movement
of
cancer
cells
to
other
parts
of
the
body.
The
body
has
natural
defenses
against
the
spread
of
cancers
to
other
tissues
(metastasis)
but
in
metastatic
cancer,
these
mechanisms
are
weakened.
Once
a
cancer
cell
has
invaded
another
tissue,
by
genomic
instability
and
mutation,
it
can
activate
the
adhesion
molecules
necessary
to
anchor
itself
in
its
new
environment.
3. Resistance
of
Apoptosis
a. Our
own
cells
die
in
a
process
called
apoptosis.
The
body
naturally
orders
cells
to
commit
suicide
in
order
to
preserve
the
integrity
of
the
body:
cells
with
high
concentrations
of
toxic
material,
excessive
amounts
of
mutations,
or
inefficient
cells
are
killed
off
by
our
own
cells.
Cancer
cells
must
evade
this
portion
of
the
normal
cell
cycle.
They
do
so
by
destroying
the
proteins
that
enable
the
process,
or
creating
more
inhibitors
(such
as
Bcl-‐2)
of
the
process.
Or,
they
may
altogether
destroy
sensors
that
allow
for
the
detection
of
abnormal
activity
in
the
cell.
4. Sustain
Proliferative
Signaling
a. Cancer
cells
undergo
constant
cell
division,
increasing
the
total
number
of
cells.
Arguably
this
may
be
the
most
fundamental
characteristic
of
all
cancer
cells
(this
is
why
it’s
in
every
scenario
in
the
diagram
above!)
In
order
to
do
this,
cancer
cells
can
lay
down
proteins
that
signal
other
cells
to
supply
growth
signals
or
activate
growth
signals
themselves,
without
the
presence
of
a
stimulus
to
elicit
the
response.
Defective
cells
can
permanently
link
certain
receptors
that
would
normally
only
occur
because
of
an
external
signals,
ensuring
that
cancer
cells
undergo
constant
cell
division.
5. Enabling
Replicative
Immortality
a. Cells
are
only
allowed
to
proliferate
a
certain
amount
of
times,
termed
the
Hayflick
limit
of
the
cell.
The
Hayflick
limit
is
determined
by
the
shortening
of
sequences
at
the
end
of
chromosomes
called
telomeres.
Each
time
a
cell
divides,
these
ends
are
shortened
by
a
certain
amount.
Once
there
is
no
telomere
left,
the
cell
enters
into
crisis,
the
sudden
death
of
a
cell.
An
enzyme,
telomerase,
extends
these
Jesus
Maldonado
B.S.
Biochemistry/Biomedical
Engineering
The
University
of
Texas
at
Austin
telomeres,
and
the
majority
of
cancers
must
express
this
enzyme
in
order
to
continuously
replicate.
6. Sustained
Angiogenesis
a. Tumors
need
vast
amounts
of
nutrients
in
order
to
sustain
their
proliferative
state.
Increased
blood
vessel
growth
must
occur
in
order
to
supply
these
nutrients.
Cancer
cells
increase
the
concentration
of
the
factors
that
determine
angiogenesis
(such
as
VEGF)
and
decrease
inhibitors
of
the
process.
Without
either
of
these
processes,
a
tumor
cannot
grow
beyond
a
certain
natural
limit
that
would
allow
it
to
invade
nearby
tissue.
Because
of
the
unchecked
expression
of
these
proteins,
tumors
show
strange
blood
vessel
growth
marked
by
contortions
and
irregularities
in
the
blood
vessels.
7. Evasion
of
Growth
Suppressors
a. Cells
contain
two
main
proteins
that
restrain
unrestricted
growth:
p53
and
Rb.
The
loss
of
either
of
these
proteins
does
not
mark
the
onset
of
cancer
usually.
Mice
studies
have
shown
that
a
loss
in
either
protein
predisposes
mice
to
cancer
later
in
life;
but
a
loss
in
both
of
these
proteins,
a
characteristic
of
tumors,
will
result
in
the
formation
of
a
cancerous
cell,
that
can
acquire
the
other
characteristics
of
cancer.
8. Avoiding
Immune
Destruction
a. Cancer
cells
must
evade
the
immune
system
if
they
are
to
proliferate
to
another
portion
of
the
body.
They
do
so
by
two
main
mechanisms:
destruction
of
the
cells
that
would
destroy
them,
by
secreting
immunosuppressive
proteins
such
as
TGF-‐β,
or
by
recruiting
immunosuppressive
cells,
like
regulatory
T
cells.
These
eight
hallmarks
and
two
enabling
characteristics
enumerate
the
various
aspects
of
cancer.
As
can
be
seen,
the
pathways
are
all
interconnected;
hallmarks
require
other
characteristics
to
be
fully
functional,
or
may
only
be
cancerous
when
combined
with
other
aspects.
For
the
same
kind
of
cancer,
different
factors
could
lead
to
the
same
disease
state
in
different
patients.
With
a
thorough
understanding
of
each
person’s
biochemistry
and
these
ten
characteristics,
a
specific
program
could
be
made
to
combat
cancer.
Reference:
Hanahan,
D.
and
Weinberg,
R.A.
Hallmarks
of
Cancer:
The
Next
Generation.
Cell,
144(5),
646-‐674,
2011.